Expedition Therapeutics

San Francisco, CA · Founded 2024 · Privately Held (backing)

Operator of biopharmaceutical development services intended for translational research and global licensing purposes. Expedition Therapeutics is based in San Francisco, CA and was founded in 2024. It was valued at $1 billion at its Series B in Aug 2026, the last priced event on record. It has raised $165 million across 1 recorded round; the latest was an $115 million Series B in Aug 2026.

PMV mark · valuation
$1.0B
Oct 2026
Priced at
its Series B
Aug 2026
Total raised
$165.0M
Last round
Series B
Aug 2026
How much has Expedition Therapeutics raised?
$165.0Macross 1 recorded rounds · Aug 2026 – Aug 2026

Most recently, Expedition Therapeutics raised $115.0M in its Series B (Aug 2026).

Free account
More of Expedition Therapeutics with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 14 names
  • ·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Expedition Therapeutics round by round

1 rounds
Aug 2026Series B$115.0M▮
General Atlanticlead+ 8 more investors · free account

How much has Expedition Therapeutics raised?

Expedition Therapeutics has raised $165 million in total; 1 of its rounds is on record. The largest on record was an $115 million Series B in Aug 2026. 1 of the rounds disclosed a post-money valuation.

Expedition Therapeutics investors

14 investors are on record for Expedition Therapeutics, including General Atlantic, RA Capital Management, Novo Holdings and Venrock. By type, the record holds 4 hedge funds, 3 venture capital firms and 1 asset manager. 1 of them led a round. The Series B in Aug 2026 drew 13 investors.

For fundraisers
Raising for a company like Expedition Therapeutics?

14 investors have backed Expedition Therapeutics.

See all 14 investors →

Frequently asked about Expedition Therapeutics

How much has Expedition Therapeutics raised?
Expedition Therapeutics has raised $165.0M in total across 1 recorded funding rounds.
Who are Expedition Therapeutics's lead investors?
Lead investors in Expedition Therapeutics's recorded rounds include General Atlantic.
When was Expedition Therapeutics's last funding round?
Expedition Therapeutics's most recent recorded round was Series B in Aug 2026, raising $115.0M.